Company page

Xbrane Biopharma Ab

Xbrane Biopharma Ab, traded under the ticker XBRANE, is a public company based in Sweden with a market capitalization of approximately 22 million USD. The company focuses on the development of biopharmaceutical products. Xbrane is committed to advancing innovative therapies to improve patient outcomes.

profileXBRANE:OMXSTOAI content: aiUpdated June 24, 2026/company/xbrane-biopharma-ab-1/c-1l7sl80g
Xbrane Biopharma Ab logo
Ticker
XBRANE:OMXSTO
Asset type
Stock
Market cap
$22.1M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
OMXSTO
Currency
SEK